28 July 2017
News and Views
Links and Services
A study in the latest issue of Inflammatory Bowel Diseases reports on the clinical implications of variations in anti-infliximab antibody levels in patients with inflammatory bowel disease.
Dr Casper Steenholdt and colleagues from Denmark investigated variations in anti
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors